Abstract
In the previous issue of Critical Care, Yu and colleagues report increased morbidity and mortality in patients after myocardial infarction undergoing prophylactic intra-aortic balloon pump support before coronary artery bypass graft surgery. The impact of prophylactic intra-aortic balloon pump implantation before coronary artery bypass graft therapy still is controversially debated. However, Yu and colleagues emphasize further discussion and substantiate the need for a prospective randomized controlled trial on this subject.
Highlights
In the previous issue of Critical Care, Yu and colleagues report increased morbidity and mortality in patients after myocardial infarction undergoing prophylactic intra-aortic balloon pump support before coronary artery bypass graft surgery
A recent prospective randomized study by Ranucci and colleagues showed no positive effect of prophylactic intra-aortic balloon pump (IABP) in patients with severely reduced left ventricular function undergoing
The ideal length of temporization of patients with myocardial infarction before coronary artery bypass graft (CABG) is subject to individual perception rather than to clinical evidence [14-16]
Summary
In the previous issue of Critical Care, Yu and colleagues report increased morbidity and mortality in patients after myocardial infarction undergoing prophylactic intra-aortic balloon pump support before coronary artery bypass graft surgery. The use of prophylactic IABP in patients undergoing CABG is based on data generated by Christenson and colleagues in the late 1990s and early 2000s showing positive effects of prophylactic IABP insertion on postoperative short-term and long-term survival [2,3,4,5]. A recent prospective randomized study by Ranucci and colleagues showed no positive effect of prophylactic IABP in patients with severely reduced left ventricular function undergoing
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have